Description
Rilpivirine, also known as TMC278, is a drug used as a part of antiretroviral therapy (ART). Rilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs